Previous Page  4 / 11 Next Page
Information
Show Menu
Previous Page 4 / 11 Next Page
Page Background

Page 30

allied

academies

J Med Oncl Ther 2017 | Volume 2 Issue 3

Breast Cancer

November 01-02, 2017 | Toronto, Canada

7

th

World Congress on

B

reast cancer remains a serious world-wide problem. It

continues to be the leading form of cancer in women

both in North America and in developing countries. More

than 200,000 women are diagnosed with breast cancer each

year in the U.S. alone. The mainstays of treatment continue

to be surgery, radiation, chemo- and endocrine therapies,

although the anti-cancer potencies of several natural agents

have entered clinical trials, including herbal supplements,

vitamins, sponge and coral derivatives, and a range of

dietary products. Notably, many are used by women with a

recent diagnosis of breast cancer without their physician’s

knowledge. Although none has proven curative, dietary

agents are seen by many as safe, low-risk alternatives to the

more potent chemotherapeutic drugs currently used against

breast cancer. One example is genistein, a soy-derived

phytoestrogen which is known to have cytoprotective as

well as cytotoxic effects on breast cancer cells. It is estimated

that over one million women consume phytoestrogens

worldwide even though questions regarding their effects on

breast cancer risk, progression, and/or treatment responses

are largely unsettled. In our studies three different human

breast cancer cell sublines were established using long-term,

low-dose exposure protocols. This was accomplished by

passing a single parental cell line inmedia supplementedwith

genistein, estradiol, or tamoxifen as well as unsupplemented

media used for controls, followed by maintenance in

parallel for a period of two years. The resulting sublines

were characterized for changes in DNA- and ligand-binding;

target gene activation; estrogen receptor expression, cell

morphology, growth and survival; as well as ploidy; cell

cycle distribution, and responses to treatment with the anti-

cancer agent paclitaxel.

e:

janice.schwartz@hc.msu.edu

The Soy – Breast Cancer Question

Janice Schwartz

1,2

and

Brigette Gerard

2

1

Michigan State University College of Osteopathic Medicine, USA

2

Wayne State University School of Medicine, USA